ArticleClinical and vaccine immunology : CVI2009

Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Gaetano Donofrio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.